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Abstract
Background: Limited evidence suggests that people from non-English speaking backgrounds in
Australia have lower than average rates of participation in cancer screening programs. The
objective of this study was to examine the distribution of bowel, breast and prostate cancer test
use by place of birth and years since migration in a large population-based cohort study in Australia.
Methods: In 2006, screening status, country of birth and other demographic and health related
factors were ascertained by self-completed questionnaire among 31,401 (16,126 women and
15,275 men) participants aged 50 or over from the 45 and Up Study in New South Wales.
Results: 35% of women and 39% of men reported having a bowel cancer test and 57% of men
reported having a prostate specific antigen (PSA) test, in the previous 5 years. 72% of women
reported having screening mammography in the previous 2 years. Compared to Australian-born
women, women from East Asia, Southeast Asia, Continental Western Europe, and North Africa/
Middle East had significantly lower rates of bowel testing, with odds ratios (OR; 95%CI) ranging
from 0.5 (0.4–0.7) to 0.7 (0.6–0.9); migrants from East Asia (0.5, 0.3–0.7) and North Africa/Middle
East (0.5, 0.3–0.9) had significantly lower rates of mammography. Compared to Australian-born
men, bowel cancer testing was significantly lower among men from all regions of Asia (OR, 95%CI
ranging from 0.4, 0.3–0.6 to 0.6, 0.5–0.9) and Continental Europe (OR, 95%CI ranging from 0.4,
0.3–0.7 to 0.7, 0.6–0.9). Only men from East Asia had significantly lower PSA testing rates than
Australian-born men (0.4, 0.3–0.6). As the number of years lived in Australia increased, cancer test
use among migrants approached Australian-born rates.
Conclusion: Certain migrant groups within the population may require targeted intervention to
improve their uptake of cancer screening, particularly screening for bowel cancer.
Background
In New South Wales (NSW), Australia's most populous
state, 31% of the population aged 45 years or older in
2006 were born outside of Australia [1]. Migration poli-
cies in Australia are complex, have changed over time and
vary from a selection of skilled migrants using a points
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system to small groups of refugees accepted on humani-
tarian grounds [2]. People born in the United Kingdom
(UK) are the largest group of migrants nationally (1.1 mil-
lion persons in 2007), followed by those born in New
Zealand (463,300), China (281,000), Italy (225,100) and
India (199,700) [3]. A large number of migrants from
Europe arrived after the Second World War, whereas many
migrants from Asia, North Africa and the Middle East
arrived in the 1970's and have increased in number since
then [2]. Focusing disease prevention programs in non-
mainstream language groups is an international and local
challenge and the purpose of this study was to identify
migrant groups in Australia that may not be receiving the
health care they need. Cancer screening participation is
known to vary by demographic factors and limited evi-
dence suggests that people from non-English speaking
backgrounds in Australia have lower than average rates of
participation in cancer screening programs [4-6]. We used
a large cohort study in NSW to investigate variation in the
use of bowel cancer tests (faecal occult blood testing –
FOBT, colonoscopy, or sigmoidoscopy), mammography,
and prostate specific antigen (PSA) tests by migrant group.
The objective was to compare screening participation or
testing across migrant groups and according to time since
migration.
Methods
Study Population
The 45 and Up Study is a population-based cohort study
of people aged 45 and over in NSW[7] Participants were
randomly sampled from Medicare Australia, Australia's
universal health insurance system, which includes all citi-
zens and permanent residents of Australia, some tempo-
rary residents and refugees. Residents in regional and
remote areas and those aged 80 and over were over-sam-
pled by a factor of two. Participants completed a mailed
self-administered questionnaire and consent form (avail-
able at http://www.45andUp.org.au) [8]. The participa-
tion rate was 18%. We report the analysis of data from
31,401 people aged 50 and over who completed the ques-
tionnaire between February 2006 and June 2006. We
chose the lower age limit of 50 years because screening for
bowel and breast cancer is not recommended for people
younger than 50 if they are at normal risk.
The 45 and Up Study has been approved by the University
of New South Wales Human Research Ethics Committee
and the Cancer Council New South Wales Ethics Commit-
tee.
Ascertainment of screening use
A self reported history of bowel and breast cancer screen-
ing was ascertained from the questions, "Have you ever
been screened for colorectal (bowel) cancer/been for a
breast screening mammogram?". History of PSA testing
was ascertained from the question, "Have you ever had a
blood test ordered by your doctor to check for prostate
disease? (PSA test)". Respondents were also asked to indi-
cate how long ago (in years) they had used each test type.
Participants reporting a personal history of bowel cancer
were excluded from bowel screening analyses as these
individuals would be undergoing more frequent surveil-
lance. Likewise, analyses of breast screening excluded
women who reported a history of breast cancer and anal-
yses of PSA testing excluded men with a personal history
of prostate cancer.
Place of birth was grouped according to a modified ver-
sion of that used in the Global Burden of Disease Study
(see Figure 1) [9].
Analyses
We compared the proportions of participants who under-
took bowel cancer or PSA tests within the last 5 years, and
mammograms within the last 2 years by place of birth,
time since migration and whether or not English was spo-
ken at home.
The prevalence of test use within the cohort was weighted
for age (according to the NSW population in 2006) [1]
and region of residence using the distribution of the NSW
population according to the Accessibility/Remoteness
Index of Australia (ARIA+; 2001) [10].
Odds ratios and 95% confidence intervals for being tested
for each type of cancer by migrant factors were estimated
using logistic regression. Each model was stratified by gen-
der and adjusted for age (4 levels: 50–59, 60–69, 70–79,
80+), highest level of education achieved (none, 10 years
of schooling – 'School Certificate', 12 years of schooling –
'Higher School Certificate'/Trade/Diploma, university
degree), family history of relevant cancer type (bowel/
breast/prostate, other, none), private health insurance sta-
tus (yes/no) and place of residence (ARIA+ 2001). The
final models did not include place of residence because it
made no difference to the odds ratios. Years lived in Aus-
tralia for migrants was analysed as a continuous variable
with an additional adjustment for place of birth. All mod-
els included a 'missing/unknown' level for each covariate.
Results
Of those in the cohort aged 50 years or over, 26.0% of
men and 22.5% of women were migrants (24.2% of the
cohort). The distribution of demographic factors by place
of birth for men and women are shown in Tables one and
two, respectively in Additional file 1
Of the 15,275 men aged 50 years or over, 1,090 reported
having been diagnosed with prostate cancer and wereBMC Public Health 2009, 9:144 http://www.biomedcentral.com/1471-2458/9/144
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Test use by place of birth Figure 1
Test use by place of birth. A) Bowel and prostate specific antigen (PSA) test use in men by place of birth relative to Austral-
ian-born. B) Bowel test and mammogram use in women by place of birth relative to Australian-born. Odds ratios are adjusted 
for age, education, family history of cancer and health insurance status.
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excluded from analyses on PSA testing. 322 men reported
ever having bowel cancer and were excluded from analy-
ses on bowel cancer testing. Of the 16,126 women aged
50 years or over, 226 reported a previous diagnosis of
bowel cancer and were excluded from analyses on bowel
cancer testing and 966 women reported a previous diag-
nosis of breast cancer and were excluded from analyses on
mammography.
Table three in Additional file 1 shows the distribution of
test use by Australian-born versus migrant participants.
Overall, 39% of men reported having a test for bowel can-
cer in the last 5 years and 57% reported having a PSA test.
The prevalence of bowel cancer test use among men,
weighted for age and region of residence, was 39%, and
for PSA test use was 56%. Thirty five percent of women
reported having a test for bowel cancer within the last 5
years and 72% reported having a mammogram in the last
2 years. The age- and region- weighted prevalence of
bowel test use for women was 34% and for mammogra-
phy was 68%.
After adjusting for age, education, family history of cancer
and health insurance status, there was significant varia-
tion in the use of bowel cancer tests across migrant
groups. Men from Oceania (OR = 0.47, 95% confidence
interval 0.24–0.92), East Asia (0.39, 0.25–0.59), South-
east Asia (0.64, 0.47–0.87), South and Central Asia (0.46,
0.27–0.76), Continental Western Europe (0.74, 0.63–
0.87), Central and East Europe (0.57, 0.44–0.76) and the
Middle East/North Africa (0.44, 0.28–0.68) reported
lower levels of bowel test use than Australian-born partic-
ipants (see Figure 1A). Similarly, men who spoke a lan-
guage other than English at home were less likely to report
using a bowel cancer test than English-only speakers
(0.60, 0.52–0.68). However, reported use of bowel cancer
tests among migrants approached Australian-born rates as
the number of years lived in Australia increased (see Fig-
ure 2A). After adjusting for place of birth, the odds of
migrant men reporting a bowel cancer test increased by
9% (1.09, 1.03–1.15, p = 0.003) with every 10 years lived
in Australia, yet remained lower than the Australian-born
rate irrespective of years lived in Australia.
There was variation in PSA test use by place of birth (Fig-
ure 1A), however only men from East Asia had signifi-
cantly lower rates of PSA test use than Australian-born
men (0.41, 0.29–0.60). Test use increased to Australian-
born rates as years lived in Australia increased (Figure 2A).
Adjusting for place of birth, the odds of migrant men
reporting a PSA test increased by 8% (1.08, 1.03–1.14, p =
0.004) with every 10 years lived in Australia. Language
spoken at home was associated with reduced use of PSA
tests (0.85, 0.75–0.96).
Women born in East Asia (0.61, 0.42–0.89), Southeast
Asia (0.51, 0.35–0.73), Continental Western Europe
(0.73, 0.60–0.88) and the Middle East/North Africa (0.50,
0.28–0.91) were significantly less likely to report having a
test for bowel cancer within the previous 5 years than Aus-
tralian-born women (see Figure 1B). Across all migrant
women, rates of bowel cancer testing approached that of
Australian-born women as the number of years since
migration increased (see Figure 2B). With every 10 years
lived in Australia, the odds of migrant women reporting a
test for bowel cancer increased by 11% (1.11, 1.05–1.18,
p = 0.001), reaching the Australian born rate after around
35 years of living in Australia. Women who spoke a lan-
guage other than English at home were less likely to report
a bowel screening test than those who spoke only English
(0.77, 0.68–0.89).
There was significant variation in mammography use by
place of birth (Figure 1B) however only women from East
Asia (0.47, 0.33–0.67) and the Middle East/North Africa
(0.53 0.32–0.86) had significantly lower rates of mam-
mography than Australian-born women. As the number
of years lived in Australia increased for migrant women,
the odds of reporting a mammogram reached those of
Australian-born participants (Figure 2B). However, after
adjusting for place of birth, mammogram use was not sig-
nificantly associated with years lived in Australia (1.06,
0.99–1.13, p = 0.08). Language spoken at home was asso-
ciated with reduced use of mammograms (0.83, 0.72–
0.96).
Discussion
We found that within a large cohort of people aged 50
years and over in Australia, there is variation in the use of
tests for bowel, breast and prostate cancer both within and
between migrant groups. The odds of bowel cancer test
use (FOBT, colonoscopy, or sigmoidoscopy) among par-
ticipants from non-English speaking backgrounds (prima-
rily Asia and Europe) was significantly lower than
Australian-born participants. Indeed, for participants who
reported speaking a language other than English at home,
the odds of reporting a test for bowel cancer within the
previous 5 years was up to 40% lower than for English-
only speakers. In contrast, mammography use among
women and PSA test use among men, did not vary widely
by migrant group. The odds of reporting a mammogram
for women born in East Asia and North Africa/Middle East
were half those for Australian-born women, and the odds
of a man born in East Asia reporting a PSA test were
reduced by 60%. Use of bowel and PSA tests by migrants
increased with increasing number of years lived in Aus-
tralia, taking about three decades to approach Australian
born rates.BMC Public Health 2009, 9:144 http://www.biomedcentral.com/1471-2458/9/144
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Test use by years lived in Australia Figure 2
Test use by years lived in Australia. A) Odds ratios for bowel and prostate specific antigen (PSA) test use in migrant men 
by years lived in Australia, compared to use in Australian-born men. B) Odds ratios for bowel test and mammogram use in 
migrant women by years lived in Australia, compared to use in Australian-born women. Odds ratios are plotted at the median 
value for each category of time since migration: 1–10 years, 11–20 years, 21–30 years, 31–40 years, and 40+ years, and are 
adjusted for age, education, family history of cancer and health insurance status.
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In Australia, a freely available program for bowel cancer
screening had not begun at the time of this survey so it is
not surprising that bowel cancer test use overall is lower
than mammography and PSA test use. Free population
screening for breast cancer has been offered to women
aged 50–69 since 1992 and has been widely advocated.
PSA testing, while not currently recommended as a popu-
lation-based screening tool for prostate cancer, is subsi-
dised by the government and has had considerable media
attention [11,12].
Among women, mammography use did not vary by
migrant group as much as bowel test use among women.
Nevertheless, women from East Asia and the Middle East/
North Africa were significantly less likely than Australian-
born women to have had a mammogram within the pre-
vious two years and these groups of women make up a
substantial proportion of the Australian population (i.e.
11% of the NSW population were born in Asia and the
Middle East/North Africa) [1]. Lower than average partic-
ipation in breast screening programs among ethnic
minority groups has also been reported in the USA [13-
16], and the breast cancer mortality rate for Asian and
Pacific Islander women in the USA increased by 302%
between 1980 and 2001 [16]. Trends in breast cancer
mortality among women from Asia and North Africa/
Middle East in Australia have not been reported, but this
would be an important issue to follow-up.
Among men, reported PSA test use did not vary widely by
migrant group. Only men from East Asia reported signifi-
cantly lower PSA test use than Australian-born men. Eth-
nic variation in PSA test use among migrant groups to the
USA have been reported [17,18]. Psychological factors
such as fear and knowledge of prostate cancer were asso-
ciated with test use. To our knowledge, cultural differ-
ences in PSA test use have not been widely explored,
nevertheless, until there is clear evidence from ran-
domised controlled trials as to whether screening with
PSA testing reduces prostate cancer mortality, the implica-
tions of a lower than average use of PSA testing are not
known.
Bowel cancer testing was significantly lower among
migrants from non-English speaking backgrounds than
for Australian-born participants. Among cultures in Asia,
Oceania, North Africa and the Middle East there may be a
lack of awareness about bowel cancer in general. Bowel
cancer incidence and mortality rates in Asia are much
lower than in Australia [19], and so compared to Austral-
ian-born people, migrants from these cultures may have
had less exposure to bowel cancer within their communi-
ties. Conversely, in most parts of Europe bowel cancer is
one of the leading cancer types and incidence and mortal-
ity rates are similar to those observed in Australia [19]. It
is unclear why migrants from continental Europe in this
cohort are less likely to have a test for bowel cancer than
Australian-born people, especially since they have similar
rates of mammography and PSA testing. Further research
to identify cultural and other barriers to bowel screening
for migrant Australians is important.
Overall, our results suggest that barriers to bowel cancer
screening arising from not having a freely available and
accessible program appear to have affected migrants from
non-English speaking backgrounds to a greater extent
than Australian-born people. However, low rates of partic-
ipation among those from non-English speaking back-
grounds were also reported in the freely available
National Bowel Cancer Screening Pilot, suggesting that
factors other than cost and accessibility are barriers to par-
ticipation among these groups [20]. Evidence from both
Australia [21-23] and elsewhere [24] suggests that a strong
predictor of cancer screening participation is encourage-
ment from health professionals. We observed that partic-
ipants who reported having a mammogram or PSA test
were more likely to also report a bowel test compared with
those who did not (Table three in Additional file 1).
Indeed, in a previous report, we found that 45 and Up
Study participants were more than twice as likely to have
a FOBT for bowel cancer if they had also had a mammo-
gram or a PSA test[25] This suggests that bowel screening
should be promoted further through existing health net-
works.
Across all the test types examined here, one group that dis-
played consistently low rates of cancer screening was par-
ticipants from East Asia. It is possible that this group of
people under-utilise health services in general. Cultural
rather than demographic factors are the likely cause of
this, as participants from East Asia were in the target age
group for cancer screening (50–59 years), were generally
well educated (e.g., 44% of East Asian men had a univer-
sity degree), primarily lived in major cities, and a high
proportion had private health insurance. These factors are
usually associated with high participation in cancer
screening programs [24]. One major barrier to screening
for people of Asian descent maybe a lack of understanding
regarding the purposes of screening [15,26-29]. In partic-
ular, research suggests that some Chinese communities
tend to feel that screening for disease is unnecessary if they
'feel well' and do not have symptoms [28,29]. The East
Asian community in Australia is large and has been
increasing consistently over time [1], so education and
awareness regarding cancer screening should be targeted
at this group.
Our finding that cancer screening among migrants
increases with the number of years since migration has
also been reported in studies elsewhere [16,30,31], and isBMC Public Health 2009, 9:144 http://www.biomedcentral.com/1471-2458/9/144
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likely to be due to factors related to acculturation. For
example, geographic history, language use and fluency,
identity, friendship circles and attitudes have been found
to reflect the degree of acculturation and are positive pre-
dictors of mammography uptake among Asian-American
women [31]. In this study, the increase in cancer screening
participation with increased years lived in Australia was
particularly apparent for bowel screening. One reason for
this is that many migrants come from places where the
incidence rate of bowel cancer is lower than in Australia
and indeed, migrants in NSW have lower rates of bowel
cancer than Australian-born residents [32]. Part of the
process of acculturation would include an increasing
awareness of bowel cancer not only via media and health
professionals, but also via community networks.
Cancer screening history in this study was derived from
self-report. A meta-analysis of validation studies on self-
reported cancer screening use in the USA found that self-
reported versus documented history of screening had rea-
sonably high sensitivity (ranging from 0.71 for PSA, to
0.95 for mammography) and specificity (ranging from
0.61 for mammography, to 0.90 for colorectal endos-
copy) [33]. However, a specific issue with self-report in
this study is that although the questionnaire specifically
asked about "screening" there was no information regard-
ing the difference between screening and diagnostic test-
ing. This may have introduced differential measurement
error if migrants had a lesser understanding of the concept
of 'screening' than Australian-born participants. If this was
the case, then a higher proportion of migrants would have
mistaken a diagnostic test for a screening test and the dif-
ferences observed in test uptake for colorectal and breast
cancer between migrants and Australian-born participants
would have been under-estimated.
Cohort study participants tend to be healthier and more
health conscious than non-participants [34]; hence, we
expect screening rates to be somewhat higher in the 45
and Up cohort than the general population. For example,
the age- and region -adjusted prevalence of bowel cancer
test use by women reported here (34%) is higher than that
reported in a previous survey of health risk factors in the
general population of women aged 50 and over in NSW
(24%) [35]. Cohort studies are designed to provide relia-
ble information on the effects of different risk factors on
outcomes, rather than population prevalence estimates
and are generalisable even when based on highly selected
groups [36,37]. Potential bias resulting from the "healthy
cohort" effect, if it is present, and the fact that the study
questionnaire was available only in English, may have led
to conservative results. The proportion of migrants in the
cohort with English as a second language was smaller than
the proportion in the NSW population [1] suggesting
reduced participation among non-English speaking
migrants. Migrants with limited skills in English may be
more likely than other participants to misunderstand the
questionnaire. These issues mean that the relative risks
associated with screening behaviour may be underesti-
mated. Caution must therefore be exercised when inter-
preting negative results. Nevertheless, our findings are
similar to those from studies using population-based reg-
istry data from the USA and Sweden where reduced rates
of mammography and bowel cancer screening were
observed among migrants, and in particular, migrants
originating from certain places in Asia [14,15,38-40].
NSW has one of the most heterogeneous populations in
the world, with almost a third of those aged 45 and over
having migrated to Australia. The 45 and Up Study is the
largest cohort study in NSW and the results presented here
describe significant variation in the use of three cancer
screening paradigms across a diverse range of migrant
groups using uniform outcome measures. The 45 and Up
study also allowed adjustment for important demo-
graphic factors related to screening use, as well as family
history of cancer and access to health services. Further, this
is the first Australian study, and the biggest internation-
ally, to describe PSA test use across different cultural
groups.
Conclusion
It is of general concern that many migrants from non-Eng-
lish speaking backgrounds are less likely to have bowel or
breast cancer screening tests than participants who were
born locally. Differences in cancer screening use between
migrants and locally-born participants were particularly
marked for bowel screening test use. However, there is
potential for FOBT rates to match those of mammography
and PSA testing and so it will be interesting to monitor
trends in screening participation within the cohort as the
National Bowel Cancer Screening Program becomes more
widely available.
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